Stephen Hoge, President at Moderna, Inc. (MRNA), sold 304 shares at $86.23 ($26K) on 2024-02-12, disclosed to the SEC on 2024-02-13.
Seasonal sale ($26k) by President — this insider has traded MRNA in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| MRNA | SELL | 2026-07-16 | $3.6M | — | Filing → |
| MRNA | SELL | 2026-06-17 | $2.7M | — | Filing → |
| MRNA | SELL | 2026-05-18 | $2.6M | — | Filing → |